Size | Price | Stock | Qty |
---|---|---|---|
2mg |
|
||
5mg |
|
||
10mg |
|
||
25mg |
|
||
50mg |
|
||
Other Sizes |
|
Purity: ≥98%
STA-21 (NSC628869; Ochromycinone; STA21; Rac-STA-21) is a potent STAT3 inhibitor and natural antibiotic with anticancer and antimicrobial activity. It inhibits STAT3 with IC50 of 12.2 μM in DU145 cells. In cells, STA-21 inhibits Stat3 DNA binding activity, Stat3 dimerization, and Stat3-dependent luciferase activity. STA-21 remarkably inhibits the growth and the survival of the breast carcinoma cells MDA-MB-231, MDA-MB-435s, and MDA-MB-468 that express persistently activated Stat3. In RH30 and RD2 cells, STA-21 also inhibits cell viability and growth and induced apoptosis through caspases 3, 8 and 9 pathways
ln Vitro |
STAT3 dimerization, STAT3-dependent luciferase activity, and STAT3 DNA binding activity are all inhibited by STA-21. Moreover, STA-21 decreased the survival of breast cancer cells that expressed constitutive STAT3 signaling, while it had no effect on those that did not [2].
|
||
---|---|---|---|
ln Vivo |
|
||
Animal Protocol |
|
||
References |
|
||
Additional Infomation |
See also: Ochromycinone (annotation moved to).
|
Molecular Formula |
C19H14O4
|
|
---|---|---|
Molecular Weight |
306.31
|
|
Exact Mass |
306.089
|
|
CAS # |
111540-00-2
|
|
Related CAS # |
(+)-Ochromycinone;28882-53-3
|
|
PubChem CID |
363709
|
|
Appearance |
Light yellow to yellow solid powder
|
|
LogP |
2.932
|
|
Hydrogen Bond Donor Count |
1
|
|
Hydrogen Bond Acceptor Count |
4
|
|
Rotatable Bond Count |
0
|
|
Heavy Atom Count |
23
|
|
Complexity |
554
|
|
Defined Atom Stereocenter Count |
0
|
|
InChi Key |
ZAWXOCUFQSQDJS-UHFFFAOYSA-N
|
|
InChi Code |
InChI=1S/C19H14O4/c1-9-7-10-5-6-12-17(15(10)14(21)8-9)19(23)11-3-2-4-13(20)16(11)18(12)22/h2-6,9,20H,7-8H2,1H3
|
|
Chemical Name |
8-hydroxy-3-methyl-3,4-dihydrotetraphene-1,7,12(2H)-trione
|
|
Synonyms |
|
|
HS Tariff Code |
2934.99.9001
|
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
|
|||
---|---|---|---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 1.67 mg/mL (5.45 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 16.7 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 3.2647 mL | 16.3233 mL | 32.6467 mL | |
5 mM | 0.6529 mL | 3.2647 mL | 6.5293 mL | |
10 mM | 0.3265 mL | 1.6323 mL | 3.2647 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.